Invention Grant
- Patent Title: Method of producing cells resistant to HIV infection
-
Application No.: US16076655Application Date: 2017-01-11
-
Publication No.: US10888613B2Publication Date: 2021-01-12
- Inventor: Charles David Pauza , Haishan Li , Tyler Lahusen
- Applicant: American Gene Technologies International, Inc.
- Applicant Address: US MD Rockville
- Assignee: American Gene Technologies International, Inc.
- Current Assignee: American Gene Technologies International, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Snell & Wilmer LLP
- International Application: PCT/US2017/013024 WO 20170111
- International Announcement: WO2017/139065 WO 20170817
- Main IPC: A61K39/21
- IPC: A61K39/21 ; A61K39/12 ; C12N15/113 ; C12N15/867 ; C12N15/86 ; A61K39/00
Abstract:
The present invention relates generally to immunotherapy for preventing HIV infection in HIV-negative individuals. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
Public/Granted literature
- US20190046633A1 HIV VACCINATION AND IMMUNOTHERAPY Public/Granted day:2019-02-14
Information query
